Are vaccination models suitable to determine whether probiotics have beneficial health effects in the general population?

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 3, 2013, Pages 621-624

  West, Nicholas P ^a   Cripps, Allan W ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Antibody; Health claims; Mucosal immunity; Probiotics; Vaccination

Indexed keywords

INTERLEUKIN 10; MINERAL; PLACEBO; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3; VITAMIN; VACCINE;

ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBODY RESPONSE; ANTIBODY TITER; ASTHMA; BIFIDOBACTERIUM ANIMALIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMMON COLD; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; DIARRHEA; GASTROINTESTINAL DISEASE; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION; INFECTIOUS DIARRHEA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; NONHUMAN; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT DISEASE; SEROCONVERSION; VACCINATION; VIRAL CLEARANCE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; ANIMAL; DRUG APPROVAL; DRUG SCREENING; IMMUNOLOGY; PROCEDURES;

ANIMALS; DRUG APPROVAL; DRUG EVALUATION; HUMANS; PROBIOTICS; T-LYMPHOCYTES, REGULATORY; VACCINES;

EID: 84874723672     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.23254     Document Type: Conference Paper

References (36)

1. Anilkumar K, Monisha AL. Role of friendly bacteria in oral health-A short review. Oral Health Prev Dent 2012; 10:3-8; PMID:22908082.
2. Twetman S, Keller MK. Probiotics for caries prevention and control. Adv Dent Res 2012; 24:98-102; PMID:22899689; http://dx.doi.org/10.1177/ 0022034512449465.
3. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004; CD003048; PMID:15106189.
4. Burcelin R, Luche E, Serino M, Amar J. The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases? Front Biosci 2009; 14:5107-17; PMID:19482607; http://dx.doi.org/10.2741/3589.
5. Hao Q, Lu Z, Dong BR, Huang CQ, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011; 9:CD006895; PMID:21901706.
6. MacDonald TT, Bell I. Probiotics and the immune response to vaccines. Proc Nutr Soc 2010; 69:442-6; PMID:20540823; http://dx.doi.org/10.1017/ S0029665110001758.
7. Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol 2012; 12:728-34; PMID:23007572; http://dx.doi.org/10.1038/nri3312.
8. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 2011; 163:250-9; PMID:21087444; http://dx.doi.org/10.1111/j.1365-2249.2010.04286.x.
9. Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, Sirard JC, et al. A key role of dendritic cells in probiotic functionality. PLoS One 2007; 2:e313; PMID:17375199; http://dx.doi.org/10.1371/journal. pone.0000313.
10. Kale-Pradhan PB, Jassal HK, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-Associated diarrhea: a meta-Analysis. Pharmacotherapy 2010; 30:119-26; PMID:20099986; http://dx.doi.org/10.1592/phco.30.2.119.
11. Videlock EJ, Cremonini F. Meta-Analysis: probiotics in antibiotic-Associated diarrhoea. Aliment Pharmacol Ther 2012; 35:1355-69; PMID:22531096; http://dx.doi.org/10.1111/j.1365-2036.2012.05104.x.
12. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-Associated diarrhea: a systematic review and meta-Analysis. JAMA 2012; 307:1959-69; PMID:22570464; http://dx.doi.org/10.1001/jama.2012.3507.
13. Salari P, Nikfar S, Abdollahi M. A meta-Analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets 2012; 11:3-14; PMID:22309079.
14. Berggren A, Lazou Ahrén I, Larsson N, Önning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 2011; 50:203-10; PMID:20803023; http://dx.doi.org/10.1007/s00394-010-0127-6.
15. Makino S, Ikegami S, Kume A, Horiuchi H, Sasaki H, Orii N. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr 2010; 104:998-1006; PMID:20487575; http://dx.doi.org/10.1017/S000711451000173X.
16. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 2011; 21:55-64; PMID:21411836.
17. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009; 124:e172-9; PMID:19651563; http://dx.doi.org/10.1542/peds.2008-2666.
18. Guillemard E, Tanguy J, Flavigny A, de la Motte S, Schrezenmeir J. Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial. J Am Coll Nutr 2010; 29:455-68; PMID:21504972.
19. West NP, Pyne DB, Cripps AW, Hopkins WG, Eskesen DC, Jairath A, et al. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratorytract illness symptoms: a randomised control trial in athletes. Nutr J 2011; 10:30; PMID:21477383; http://dx.doi.org/10.1186/1475-2891-10-30.
20. Van Puyenbroeck K, Hens N, Coenen S, Michiels B, Beunckens C, Molenberghs G, et al. Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am J Clin Nutr 2012; 95:1165-71; PMID:22440853; http://dx.doi.org/10. 3945/ajcn.111.026831.
21. Gleeson M, Bishop NC, Oliveira M, McCauley T, Tauler P, Lawrence C. Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes. Int J Sport Nutr Exerc Metab 2012; 22:235-42; PMID:22645171.
22. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 2006; 24:6670-4; PMID:16844267; http://dx.doi.org/10.1016/j.vaccine.2006.05.048. (Pubitemid 46107165)
23. Christensen HR, Larsen CN, Kaestel P, Rosholm LB, Sternberg C, Michaelsen KF, et al. Immunomodulating potential of supplementation with probiotics: a doseresponse study in healthy young adults. FEMS Immunol Med Microbiol 2006; 47:380-90; PMID:16872374; http://dx.doi.org/10.1111/j.1574-695X.2006.00109.x. (Pubitemid 44035888)
24. Donovan SM, Schneeman B, Gibson GR, Sanders ME. Establishing and evaluating health claims for probiotics. Adv Nutr 2012; 3:723-5; PMID:22983853; http://dx.doi.org/10.3945/an.112.002592.
25. EFSA on Dietetic Products. Nutrition and Allergies (NDA); Guidance on the scientific requirements for health claims related to gut and immune function. EFSA Journal. In: EFSA, ed. 9(4), 2011:12.
26. Liu J, Ruckwardt TJ, Chen M, Nicewonger JD, Johnson TR, Graham BS. Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection. J Virol 2010; 84:10501-9; PMID:20686045; http://dx.doi.org/10.1128/JVI.00963-10.
27. Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol 2009; 39:2331-6; PMID:19662638; http://dx.doi.org/10.1002/eji.200939688.
28. Wang X, Liu F, Zhou S, Xu Z, Hoellwarth J, Chen X, et al. Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection. PLoS One 2012; 7:e40359; PMID:22802961; http://dx.doi.org/10.1371/journal.pone.0040359.
29. Li S, Roberts S, Plebanski M, Gouillou M, Spelman T, Latour P, et al. Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals. PLoS One 2012; 7:e39368; PMID:22905088; http://dx.doi.org/10.1371/journal.pone.0039368.
30. Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 2011; 89:685-95; PMID:21233408; http://dx.doi.org/10.1189/jlb.1109753.
31. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010; 40:103-10; PMID:19817754.
32. Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One 2009; 4:e4903; PMID:19300508; http://dx.doi.org/10. 1371/journal.pone.0004903.
33. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009; 179:186-93; PMID:19029003; http://dx.doi.org/10.1164/rccm.200806-951OC.
34. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011; 241:241-59; PMID:21488901; http://dx.doi.org/10.1111/j.1600-065X.2011. 01017.x.
35. Ostler T, Davidson W, Ehl S. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur J Immunol 2002; 32:2117-23; PMID:12209623; http://dx.doi.org/10. 1002/1521-4141(200208)32:8<2117::AIDIMMU2117> 3.0.CO;2-C. (Pubitemid 34965874)
36. Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol 2009; 83:3019-28; PMID:19153229; http://dx.doi.org/10.1128/JVI.00036-09.